Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Sylvia Taylor, PhD, MPH, MBA

Medical Evidence, Vaccines and Immune Therapies Unit, AstraZeneca, Cambridge, UK, United Kingdom

Disclosure(s): AstraZeneca: Employee of, and may hold stock and/or stock options in, AstraZeneca

Poster(s):

(P-1989) COVID-19 Mortality Among Immunocompromised Individuals is Consistently High Compared with Non-Immunocompromised Individuals: Results of the INFORM Study 2022, England

Saturday, October 19, 2024
12:15 PM – 1:30 PM US PT
(P-2006) Individuals on Immunosuppressive or Immunomodulatory Therapies Remain at Increased Risk of COVID-19 Hospitalization, Despite Vaccination: Findings from INFORM, a Retrospective Health Database Study in England

Saturday, October 19, 2024
12:15 PM – 1:30 PM US PT